A Case of Switching from GnRH Agonist to Antagonist for Castration Resistant Prostate Cancer Control
GnRH antagonist and GnRH agonist are widely used as androgen deprivation therapy for metastatic prostate cancer. A previous report demonstrated that patients with PSA levels of >20 ng/mL using GnRH antagonists showed favorable outcomes in comparison to those using GnRH agonists. An 82-year old...
Guardat en:
| Autors principals: | , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Karger Publishers
2019-09-01
|
| Col·lecció: | Case Reports in Oncology |
| Matèries: | |
| Accés en línia: | https://www.karger.com/Article/FullText/502859 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|